Tanshinone IIA promotes cardiac differentiation and improves cell motility by modulating the Wnt/β‑catenin signaling pathway

Li,Kun; Wang,Xiuyan; Fan,Chenxing; Wu,Chunxia; Li,Shizheng; Liu,Hua

doi:10.3892/mmr.2020.11272

Tanshinone IIA promotes cardiac differentiation and improves cell motility by modulating the Wnt/β‑catenin signaling pathway

Authors:
- Kun Li
- Xiuyan Wang
- Chenxing Fan
- Chunxia Wu
- Shizheng Li
- Hua Liu
View Affiliations

Affiliations: Department of Clinical Laboratory, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China, Department of General Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China, Institute of Eyes, Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China
Published online on: June 24, 2020 https://doi.org/10.3892/mmr.2020.11272
Pages: 1839-1846
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although the cardiovascular pharmacological actions of Tanshinone IIA (TanIIA) have been extensively studied, research on its roles in cardiac regeneration is still insufficient. The present study employed the cardiac myoblast cell line H9c2 to evaluate the possible roles of TanIIA in cardiac regeneration. It was found that certain concentration of TanIIA inhibited cell proliferation by suppressing the expression of proteins related to the cell cycle [cyclin dependent kinase (CDK)4, CDK6 and cyclin D1] and proliferation [c‑Myc, octamer‑binding transcription factor 4 (Oct4) and proliferating cell nuclear antigen (PCNA)] without inducing apoptosis. In this process, the expression of cardiac troponin in the treated cells was significantly increased and the migration of the treated cells toward the wound area was significantly enhanced. Meanwhile, TanIIA inhibited the canonical signaling pathway through increasing the expression of glycogen synthase kinase 3β (GSK‑3β) and adenomatous polyposis coli (APC) and increased the expression of Wnt11 and Wnt5a in the noncanonical Wnt signaling pathway. Following β‑catenin agonist WAY‑262611 intervention, the effect of TanIIA on the promotion of cardiac differentiation and improved cell migration was significantly reduced. In conclusion, it was hypothesized that TanIIA could promote cardiac differentiation and improve cell motility by modulating the Wnt/β‑catenin signaling pathway. These results suggest that TanIIA may play beneficial roles in myocardial regeneration following stem cell transplantation.

View Figures

View References

1	Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, et al: Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation. 139:e56–e528. 2019. View Article : Google Scholar : PubMed/NCBI
2	Yu H, Lu K, Zhu J and Wang J: Stem cell therapy for ischemic heart diseases. Br Med Bull. 121:135–154. 2017. View Article : Google Scholar : PubMed/NCBI
3	Kadota S and Shiba Y: Pluripotent stem cell-derived cardiomyocyte transplantation for heart disease treatment. Curr Cardiol Rep. 21:732019. View Article : Google Scholar : PubMed/NCBI
4	Fouts K, Fernandes B, Mal N, Liu J and Laurita KR: Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium. Heart Rhythm. 3:452–461. 2006. View Article : Google Scholar : PubMed/NCBI
5	Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, et al: Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 27:743–745. 2009. View Article : Google Scholar : PubMed/NCBI
6	Sougawa N, Miyagawa S, Fukushima S, Kawamura A, Yokoyama J, Ito E, Harada A, Okimoto K, Mochizuki-Oda N, Saito A and Sawa Y: Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy. Sci Rep. 8:37262018. View Article : Google Scholar : PubMed/NCBI
7	Gulbins H, Meiser BM, Reichenspurner H and Reichart B: Cell transplantation-a potential therapy for cardiac repair in the future? Heart Surg Forum. 5:E28–E34. 2002.PubMed/NCBI
8	Hashimoto H, Olson EN and Bassel-Duby R: Therapeutic approaches for cardiac regeneration and repair. Nat Rev Cardiol. 15:585–600. 2018. View Article : Google Scholar : PubMed/NCBI
9	Kang YJ, Jin UH, Chang HW, Son JK, Lee SH, Son KH, Chang YC, Lee YC and Kim CH: Inhibition of microsomal triglyceride transfer protein expression and atherogenic risk factor apolipoprotein B100 secretion by tanshinone IIA in HepG2 cells. Phytother Res. 22:1640–1645. 2008. View Article : Google Scholar : PubMed/NCBI
10	Adams JD, Wang R, Yang J and Lien EJ: Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin Med. 1:32006. View Article : Google Scholar : PubMed/NCBI
11	Li CZ, Yang SC and Zhao FD: Effects of tanshinone II-A sulfonate on thrombus formation, platelet and blood coagulation in rats and mice. Zhongguo Yao Li Xue Bao. 5:39–42. 1984.(In Chinese). PubMed/NCBI
12	Jang SI, Kim HJ, Kim YJ, Jeong SI and You YO: Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: Possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol. 542:1–7. 2006. View Article : Google Scholar : PubMed/NCBI
13	Wu GB, Zhou EX and Qing DX: Tanshinone II(A) elicited vasodilation in rat coronary arteriole: Roles of nitric oxide and potassium channels. Eur J Pharmacol. 617:102–107. 2009. View Article : Google Scholar : PubMed/NCBI
14	Wan AK, Leung SW, Zhu DY and Man RY: Vascular effects of different lipophilic components of ‘Danshen’, a traditional Chinese medicine, in the isolated porcine coronary artery. J Nat Prod. 71:1825–1828. 2008. View Article : Google Scholar : PubMed/NCBI
15	Shang Q, Xu H and Huang L: TanshinoneIIA: A promising natural cardioprotective agent. Evid Based Complement Alternat Med. 2012:7164592012. View Article : Google Scholar : PubMed/NCBI
16	Wu TW, Zeng LH, Fung KP, Wu J, Pang H, Grey AA, Weisel RD and Wang JY: Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. Biochem Pharmacol. 46:2327–2332. 1993. View Article : Google Scholar : PubMed/NCBI
17	Li K, Song J, Zhao Q, Wang B, Zhang Y, Wang X, Tang T and Li S: Effective component of Salvia miltiorrhiza in promoting cardiomyogenic differentiation of human placenta-derived mesenchymal stem cells. Int J Mol Med. 41:962–968. 2018.PubMed/NCBI
18	Gessert S and Kühl M: The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ Res. 107:186–199. 2010. View Article : Google Scholar : PubMed/NCBI
19	Parikh A, Wu J, Blanton RM and Tzanakakis ES: Signaling pathways and gene regulatory networks in cardiomyocyte differentiation. Tissue Eng Part B Rev. 21:377–392. 2015. View Article : Google Scholar : PubMed/NCBI
20	Pandur P, Läsche M, Eisenberg LM and Kühl M: Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature. 418:636–641. 2002. View Article : Google Scholar : PubMed/NCBI
21	Li D, Sinha T, Ajima R, Seo HS, Yamaguchi TP and Wang J: Spatial regulation of cell cohesion by Wnt5a during second heart field progenitor deployment. Dev Biol. 412:18–31. 2016. View Article : Google Scholar : PubMed/NCBI
22	Bisson JA, Mills B, Paul Helt JC, Zwaka TP and Cohen ED: Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT. Dev Biol. 398:80–96. 2015. View Article : Google Scholar : PubMed/NCBI
23	Cohen ED, Miller MF, Wang Z, Moon RT and Morrisey EE: Wnt5a and Wnt11 are essential for second heart field progenitor development. Development. 139:1931–1940. 2012. View Article : Google Scholar : PubMed/NCBI
24	Liu AR, Liu L, Chen S, Yang Y, Zhao HJ, Liu L, Guo FM, Lu XM and Qiu HB: Activation of canonical wnt pathway promotes differentiation of mouse bone marrow-derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro. J Cell Physiol. 228:1270–1283. 2013. View Article : Google Scholar : PubMed/NCBI
25	Sumi D, Abe K and Himeno S: Arsenite retards the cardiac differentiation of rat cardiac myoblast H9c2 cells. Biochem Biophys Res Commun. 436:175–179. 2013. View Article : Google Scholar : PubMed/NCBI
26	Branco AF, Pereira SP, Gonzalez S, Gusev O, Rizvanov AA and Oliveira PJ: Gene expression profiling of H9c2 myoblast differentiation towards a cardiac-like phenotype. PLoS One. 10:e01293032015. View Article : Google Scholar : PubMed/NCBI
27	Shafiq M, Lee SH, Jung Y and Kim SH: Strategies for recruitment of stem cells to treat myocardial infarction. Curr Pharm Des. 21:1584–1597. 2015. View Article : Google Scholar : PubMed/NCBI
28	Shi M, Li J, Liao L, Chen B, Li B, Chen L, Jia H and Zhao RC: Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: Role in homing efficiency in NOD/SCID mice. Haematologica. 92:897–904. 2007. View Article : Google Scholar : PubMed/NCBI
29	Andres RH, Choi R, Pendharkar AV, Gaeta X, Wang N, Nathan JK, Chua JY, Lee SW, Palmer TD, Steinberg GK and Guzman R: The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke. 42:2923–2931. 2011. View Article : Google Scholar : PubMed/NCBI
30	Carotenuto F, Teodori L, Maccari AM, Delbono L, Orlando G and Di Nardo P: Turning regenerative technologies into treatment to repair myocardial injuries. J Cell Mol Med. 24:2704–2716. 2020. View Article : Google Scholar : PubMed/NCBI
31	Chen FY, Guo R and Zhang BK: Advances in cardiovascular effects of tanshinone II(A). Zhongguo Zhong Yao Za Zhi. 40:1649–1653. 2015.(In Chinese). PubMed/NCBI
32	Xu W, Yang J and Wu LM: Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats. Pharmazie. 64:332–336. 2009.PubMed/NCBI
33	Zhang Y, Wei L, Sun D, Cao F, Gao H, Zhao L, Du J, Li Y and Wang H: Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats. Diabetes Obes Metab. 12:316–322. 2010. View Article : Google Scholar : PubMed/NCBI
34	Li K, Li SZ, Zhang YL and Wang XZ: The effects of dan-shen root on cardiomyogenic differentiation of human placenta-derived mesenchymal stem cells. Biochem Biophys Res Commun. 415:147–151. 2011. View Article : Google Scholar : PubMed/NCBI
35	Hakuno D, Takahashi T, Lammerding J and Lee RT: Focal adhesion kinase signaling regulates cardiogenesis of embryonic stem cells. J Biol Chem. 280:39534–39544. 2005. View Article : Google Scholar : PubMed/NCBI
36	Wei H, Juhasz O, Li J, Tarasova YS and Boheler KR: Embryonic stem cells and cardiomyocyte differentiation: Phenotypic and molecular analyses. J Cell Mol Med. 9:804–817. 2005. View Article : Google Scholar : PubMed/NCBI
37	Stamos JL and Weis WI: The β-catenin destruction complex. Cold Spring Harb Perspect Biol. 5:a0078982013. View Article : Google Scholar : PubMed/NCBI
38	Mohammed MK, Shao C, Wang J, Wei Q, Wang X, Collier Z, Tang S, Liu H, Zhang F, Huang J, et al: Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis. 3:11–40. 2016. View Article : Google Scholar : PubMed/NCBI